| MeSH term | MeSH ID | Detail |
|---|---|---|
| Otitis Media | D010033 | 12 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Whooping Cough | D014917 | 6 associated lipids |
| Fecal Impaction | D005244 | 1 associated lipids |
Total
4
ERYTHROMYCIN ESTOLATE
ERYTHROMYCIN ESTOLATE is a lipid of Polyketides (PK) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 675 references associated with ERYTHROMYCIN ESTOLATE in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for ERYTHROMYCIN ESTOLATE
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with ERYTHROMYCIN ESTOLATE
All references with ERYTHROMYCIN ESTOLATE
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Aleo MD et al. | Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals. | 2017 | Chem. Res. Toxicol. | pmid:28437613 |
| Lu X et al. | Integrated systems toxicology approaches identified the possible involvement of ABC transporters pathway in erythromycin estolate-induced liver injury in rat. | 2014 | Food Chem. Toxicol. | pmid:24412560 |
| Morgan RE et al. | A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. | 2013 | Toxicol. Sci. | pmid:23956101 |
| Raynes Greenow CH et al. | Antibiotics for ureaplasma in the vagina in pregnancy. | 2011 | Cochrane Database Syst Rev | pmid:21901685 |
| Morgan RE et al. | Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. | 2010 | Toxicol. Sci. | pmid:20829430 |
| Albarellos GA et al. | Pharmacokinetics of erythromycin after the administration of intravenous and various oral dosage forms to dogs. | 2008 | J. Vet. Pharmacol. Ther. | pmid:19000270 |
| Zidek N et al. | Acute hepatotoxicity: a predictive model based on focused illumina microarrays. | 2007 | Toxicol. Sci. | pmid:17522070 |
| Altunaiji S et al. | Antibiotics for whooping cough (pertussis). | 2007 | Cochrane Database Syst Rev | pmid:17636756 |
| Altunaiji S et al. | Antibiotics for whooping cough (pertussis). | 2005 | Cochrane Database Syst Rev | pmid:15674946 |
| Murugan P and Pari L | Effect of tetrahydrocurcumin on erythromycin estolate-induced lipid peroxidation in rats. | 2005 | J Basic Clin Physiol Pharmacol | pmid:16187483 |
| Langley JM et al. | Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. | 2004 | Pediatrics | pmid:15231980 |
| Pari L and Murugan P | Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. | 2004 | Pharmacol. Res. | pmid:14998559 |
| Park SJ and Kim SH | Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique. | 2004 | J Colloid Interface Sci | pmid:14972610 |
| Pari L and Uma A | Protective effect of Sesbania grandiflora against erythromycin estolate-induced hepatotoxicity. | 2003 Sep-Oct | Therapie | pmid:14682193 |
| de Longueville F et al. | Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. | 2003 | Toxicol. Sci. | pmid:12883083 |
| Bellomo-Brandão MA et al. | Use of erythromycin for the treatment of severe chronic constipation in children. | 2003 | Braz. J. Med. Biol. Res. | pmid:14502372 |
| Lavoie JP et al. | Equine proliferative enteropathy: a cause of weight loss, colic, diarrhoea and hypoproteinaemia in foals on three breeding farms in Canada. | 2000 | Equine Vet. J. | pmid:11037264 |
| Lai CC et al. | Analysis of a commercial preparation of erythromycin estolates by tandem mass spectrometry and high performance liquid chromatography/electrospray ionization tandem mass spectrometry using an ion trap mass spectrometer. | 2000 | Rapid Commun. Mass Spectrom. | pmid:10717658 |
| Halperin SA et al. | A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection. | 1999 | Pediatrics | pmid:10506267 |
| Scholz H and Noack R | Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. AOM Study Group. | 1998 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:9764549 |
| Venkateswaran S et al. | Protective effect of Livex, a herbal formulation against erythromycin estolate induced hepatotoxicity in rats. | 1997 | J Ethnopharmacol | pmid:9292408 |
| Halperin SA et al. | Seven days of erythromycin estolate is as effective as fourteen days for the treatment of Bordetella pertussis infections. | 1997 | Pediatrics | pmid:9200361 |
| Adam D and Scholz H | Five days of erythromycin estolate versus ten days of penicillin V in the treatment of group A streptococcal tonsillopharyngitis in children. Pharyngitis Study Group. | 1996 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:8922570 |
| Potthast H et al. | [Comparison of the bioavailabilities of erythromycin estolate and erythromycin ethylsuccinate dry suspension preparations in steady state]. | 1995 | Pharmazie | pmid:7886126 |
| Gilbert FI | Cholestatic hepatitis caused by esters of erythromycin and oleandomycin. 1962. | 1995 | Hawaii Med J | pmid:7642362 |
| Thibault N et al. | Effect of tauroursodeoxycholate on actin filament alteration induced by cholestatic agents. A study in isolated rat hepatocyte couplets. | 1993 | J. Hepatol. | pmid:8151096 |
| Snellman LW et al. | Duration of positive throat cultures for group A streptococci after initiation of antibiotic therapy. | 1993 | Pediatrics | pmid:8502522 |
| Cachet T et al. | Analysis of erythromycin estolate by liquid chromatography. | 1992 Oct-Dec | J Pharm Biomed Anal | pmid:1298393 |
| Villa P et al. | Protective effect of diosmetin on in vitro cell membrane damage and oxidative stress in cultured rat hepatocytes. | 1992 | Toxicology | pmid:1609428 |
| Hillyer D | Is erythromycin indicated in pregnancy? | 1992 | RN | pmid:1594870 |
| Hoppe JE | Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis. The Erythromycin Study Group. | 1992 | Pediatr. Infect. Dis. J. | pmid:1565532 |
| Saiz Santos S and Montero López L | [Hepatotoxicity from erythromycin estolate]. | 1992 | Aten Primaria | pmid:1467424 |
| Amacher DE et al. | Comparison of the effects of the new azalide antibiotic, azithromycin, and erythromycin estolate on rat liver cytochrome P-450. | 1991 | Antimicrob. Agents Chemother. | pmid:1656856 |
| Ramin U and Wollmann H | [Problems in the determination of water content of lubomycin B capsules]. | 1990 | Pharmazie | pmid:2080216 |
| Bocka JJ | Pertussis in an infant. | 1989 Jul-Aug | J Emerg Med | pmid:2689510 |
| Klein MD | Streptococcal pharyngitis in children. | 1989 | Pediatr Emerg Care | pmid:2690022 |
| Davila JC et al. | Protective effect of flavonoids on drug-induced hepatotoxicity in vitro. | 1989 | Toxicology | pmid:2756528 |
| Stubbs C and Kanfer I | Variability in the absorption and disposition of erythromycin estolate in humans. | 1989 | J Pharm Sci | pmid:2778669 |
| Farre M | Erythromycin propionate and estolate. | 1988 | Lancet | pmid:2898648 |
| Villa P et al. | Toxicity, uptake, and subcellular distribution in rat hepatocytes of roxithromycin, a new semisynthetic macrolide, and erythromycin base. | 1988 | Antimicrob. Agents Chemother. | pmid:3190183 |
| Bérubé D et al. | Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers. | 1988 | Antimicrob. Agents Chemother. | pmid:3142349 |
| Croteau D et al. | Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography. | 1988 | Antimicrob. Agents Chemother. | pmid:3259856 |
| Laperrière H and Lefebvre J | Persistence of inclusion conjunctivitis after oral erythromycin therapy. | 1988 | CMAJ | pmid:3179892 |
| Punch PI et al. | The release of insoluble antibiotics from collagen ocular inserts in vitro and their insertion into the conjunctival sac of cattle. | 1987 | J. Vet. Pharmacol. Ther. | pmid:3586121 |
| Torre D et al. | Erythromycin estolate for treatment of pertussis. | 1986 Nov-Dec | Pediatr Infect Dis | pmid:3797311 |
| Derrick CW et al. | Erythromycin in the treatment of streptococcal infections. | 1986 Jan-Feb | Pediatr Infect Dis | pmid:3945572 |
| Ginsburg CM | Pharmacology of erythromycin in infants and children. | 1986 Jan-Feb | Pediatr Infect Dis | pmid:3753798 |
| Ginsburg CM | A prospective study on the incidence of liver function abnormalities in children receiving erythromycin estolate, erythromycin ethylsuccinate or penicillin V for treatment of pneumonia. | 1986 Jan-Feb | Pediatr Infect Dis | pmid:3080735 |
| Griffith RS | Pharmacology of erythromycin in adults. | 1986 Jan-Feb | Pediatr Infect Dis | pmid:3511455 |
| Zarrabi MH and Rosner F | Rarity of failure of penicillin prophylaxis to prevent postsplenectomy sepsis. | 1986 | Arch. Intern. Med. | pmid:3521520 |